Latest Updates

June 2, 2022

Kedma Capital acquires "Zriha Hlavin Industries"

Adv. Ilan Blumenfeld, Hagit Ross and Dor Levi-Tam represented the sellers in the transaction for the sale of all their shares in Zriha Hlavin to Kedma Capital.

See full article >

May 26, 2022

SightVision Completes Acquisition of Terravision

SightVision Information Systems Ltd. has completed a 100% acquisition of Terravision Ltd., which develops applications and provides services in the geographical field, and has been developing advanced mapping systems for over 30 years. SightVision also completed the acquisition of 100% of the rights in the partnership Terra-Design 3D Mapping, which provides 3D modeling services. Advs. Ilan Blumenfeld and Dor Levi-Tam represented SightVision in the transaction.

May 24, 2022

Danel Acquires Additional 10% of Enaim Medical Center

The NIS 43 million acquisition will make Danel the owner of 61% of Enaim Medical Center. Advs. Ilan Blumenfeld and Daniel Kleinman represented Danel in the transaction.

See full article >

May 22, 2022

BioGenCell Completes USD 16 Million Seed Round

Our firm represents BioGenCell, a stem cell research and development company located at Laniado Hospital. The company recently announced the completion of a USD 16 million seed round investment, aided by counsel from Advs. Itay Gura and Inbar Katzir. Our firm has represented the company since its inception.

See full article >

April 14, 2022

Migdal Group invests in Scandinavian energy

Migdal Group has invested, together with other partnerships, in the alternative energy projects of Fu-Gen AG and Fu-Gen Assets 4 AB. Firm partners Micky Barnea, Ariella Dreyfuss, and Roy Engel advised on the NIS 1 billion investment.

See full article >

April 10, 2022

Supreme Court Reverses Decision to Shorten Pfizer’s Viagra Patent Period

Two patents protected Pfizer’s Viagra medication in Israel. When one expired, the district court ruled the second had as well. The Supreme Court, however, determined otherwise.

See full article >

April 5, 2022

Barnea: Representing Kibbutz Shefayim and Yad Hana in Transaction to Sell Land Designated for Logistics Complex

Mivna Group has acquired 50% of the shares of the Yad Hana Homesh Industries Cooperative Association for ILS 140 million. The parties intend to jointly establish an innovative logistics center in a total built-up area of about 100,000 square meters. The client was represented by Advs. Ilan Blumenfeld and Maya Zisser.

See full article >

March 29, 2022

Representing Menora Mivtachim in Acquisition of Nisko Shares

Our firm represented Menora Mivtachim Insurance Ltd., Shomera Insurance Company Ld., and Menora Pension and Provident Ltd. in a transaction to purchase 15% of Nisko Group's shares for NIS 180 million. Advs. Ilan Blumenfeld and Dor Levi-Tam advised on the transaction.

See full article >

March 28, 2022

Significant Change in Format to Report Mergers to Competition Authority

The new format heralds a reduction in the volume of transactions that require reporting. However, it imposes a far heavier burden on parties to transactions that do require reporting, even for mergers posing no competitive concerns.

See full article >

March 22, 2022

Representing Danel Group in Completion of Acquisition of Manor Medical

Advs. Micky Barnea, Ilan Blumenfeld, and Daniel Kleinman from our firm represented Danel Group in the acquisition of Manor Medical, which operates in the surrogacy, egg donation, and medical tourism fields. This transaction constitutes the completion of Danel’s acquisition of Manor Medical based on a NIS 100 million valuation.

See full article >

March 9, 2022

Barnea: Representation of the Azrieli Group in the purchase of Labs' workspace for NIS 130 million

Adv. Sagi Gross, Daniel Kleinman, Izabel Pashayev, and Dor Levi-Tam represented Azrieli in an acquisition of Labs from the businessman Teddy Sagi. The workspace complex in the Sharona Tower includes office space, venues hall, a lounge, and a gym. The Labs International network includes several locations around the world including London.

See full article >

March 7, 2022

Warburg Pincus Leads Funding Round in Israeli Digital Health Startup MDClone

We were delighted to represent the global private equity firm Warburg Pincus in its investment in the Israeli Healthcare Data Analysis company MDClone. Advs. Ariella Dreyfuss, Tal Freilich and Anat Even-Chen advised on this transaction.

See full article >

March 3, 2022

Shift 4 Acquires Israeli Clearing Technology Company Finaro

Shift4 Payments, an American public company, has acquired Finaro for a value of USD 575 million. Advs. Simon Jaffa, Ariella Dreyfuss, Mayer Winkler, Harel Perlmutter, Hanna Daher, and Fadi Atallah advised on the transaction.

February 10, 2022

Israeli Amutot Business Activity – When Permitted and Under What Conditions?

Many believe the law prohibits an Israeli NPO (Amutah) from operating business activity in order to maximize profits for itself. One of the reasons for this is the language of section 1 of the Amutot Law. A more precise reading of the section shows it does not expressly prohibit such activity, but stresses its conditions.

See full article >

February 9, 2022

Representing Shareholders in Startup's Acquisition by Vontier

We represented Inven Capital, Volvo Group Venture Capital, and Ombu Group in the sale of their shares in Driivz to Vontier, a global mobility company. Simon Jaffa, Ariella Dreyfuss, Harel Perlmutter, and Fadi Atallah from our office advised on the transaction.

See full article >

February 2, 2022

Interview with Micky Barnea: Takeovers of Public Companies

Recent years have seen several takeover attempts of companies listed on the Tel Aviv Stock Exchange. Already in early 2022 was there a control struggle over Norstar Holdings Inc. As an expert lawyer in the field of corporate takeovers, Micky Barnea was interviewed by TheMarker for an article on the subject. In the interview, Micky explained that “control takeovers begin with a combination of two things: an analysis to identify the business potential and a legal analysis that clarifies which steps are required to acquire control.”

See full article >

January 12, 2022

A Share Deal or An Asset Deal in Israeli Mergers & Acquisitions?

You have identified an Israeli target company to purchase. Now the question is how to structure the acquisition? There are two traditional routes in Israeli private MA transactions. The first is to purchase the shares of the target company, and the second is to purchase its assets. Each structure has benefits and disadvantages for the purchaser.

See full article >

January 10, 2022

Corporate Law between Theory and Practice

Ilan Blumenfeld, a partner in our firm, lectured to students of a course on corporations at the College of Management on mergers and acquisitions and the various stages of MA transactions.

January 3, 2022

Representing Migdal in USD 20 Million Investment

Migdal is investing USD 20 million in Tipa, an Israeli cleantech company that is developing and marketing compostable flexible packaging solutions for foods and various other consumer goods. Our firm is advising Migdal, who took part in Tipa’s investment round alongside Millennium Food-Tech and Meitav Dash. Itay Gura and Inbar Katzir represented Migdal in the transaction.

See full article >

December 21, 2021

Barnea Representing Ness in Acquisition of DXC's Operations for USD 65 Million

Our firm is representing Ness Technologies, owned by Hilan, a TASE-traded software company, in a transaction to acquire 100% of the share capital of DXC Technology's IT services company in Israel (formerly EDS). The scope of the transaction is USD 65 million, and its completion is expected at the end of the first quarter of 2022. Advs. Micky Barnea, Yuval Lazi, Mayer Winkler, and Dana Ben-Yehuda represent Ness in the transaction.

See full article >

Search by Practice

Latest Updates / Corporate